Search for content, post, videos

Gedea Biotech obtains US patent

The United States Patent and Trademark Office (USPTO) has granted the company's patent application directed to gluconic acid derivatives for preventing and/or treating bacterial infections. “The US patent covering treatment and prevention of vaginal bacterial infections by GDL, or pHyph, streng
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.